Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Methamphetamine Dependence, Psychological Well-being, Criminality and High Risk Sexual Behaviors in Female-Only Methadone Services in Tehran and Karaj, Iran

Omid Massah 1 , * and Sara Shishehgar 2
Authors Information
1 Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran
2 Faculty of Health, University of Technology Sydney, Sydney, Australia
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2018, 12 (2); e61859
  • Published Online: February 26, 2018
  • Article Type: Brief Report
  • Received: February 18, 2017
  • Revised: April 24, 2017
  • Accepted: September 27, 2017
  • DOI: 10.5812/ijpbs.61859

To Cite: Massah O, Shishehgar S. Methamphetamine Dependence, Psychological Well-being, Criminality and High Risk Sexual Behaviors in Female-Only Methadone Services in Tehran and Karaj, Iran, Iran J Psychiatry Behav Sci. 2018 ; 12(2):e61859. doi: 10.5812/ijpbs.61859.

Copyright © 2018, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. United Nations Office on Drugs. World Drug Report 2004. 1. United Nations Publications; 2004.
  • 2. Mehrjerdi ZA, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran. Int J STD AIDS. 2014;25(6):420-7. doi: 10.1177/0956462413512806. [PubMed: 24287028].
  • 3. Alam Mehrjerdi Z, Barr AM, Noroozi A. Methamphetamine-associated psychosis: a new health challenge in Iran. Daru. 2013;21(1):30. doi: 10.1186/2008-2231-21-30. [PubMed: 23577655].
  • 4. Alam Mehrjerdi Z. Crystal in Iran: methamphetamine or heroin kerack. Daru. 2013;21(1):22. doi: 10.1186/2008-2231-21-22. [PubMed: 23497450].
  • 5. Javadian S, Shabani A, Shariat SV. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up. Prim Care Companion CNS Disord. 2016;18(6). doi: 10.4088/PCC.16m02002. [PubMed: 27907276].
  • 6. Dolatshahi B, Farhoudian A, Falahatdoost M, Tavakoli M, Rezaie Dogahe E. A Qualitative Study of the Relationship Between Methamphetamine Abuse and Sexual Dysfunction in Male Substance Abusers. Int J High Risk Behav Addict. 2016;5(3). e29640. doi: 10.5812/ijhrba.29640. [PubMed: 27803891].
  • 7. Shadloo B, Amin-Esmaeili M, Haft-Baradaran M, Noroozi A, Ghorban-Jahromi R, Rahimi-Movaghar A. Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review. East Mediterr Health J. 2017;23(3):245-56. [PubMed: 28493273].
  • 8. Rafiey H, Ghaderi S, Morovat B, Noori R, Effatpanah M, Mahjoub A, et al. Amphetamine Type Stimulants Use in the Adult Population of Tehran: Implications for Long Term Rehabilitation. Iran Rehabil J. 2017;15(4):303-8. doi: 10.29252/nrip.irj.15.4.303.
  • 9. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington; 2000.
  • 10. Khosravi A, Mousavi SA, Chaman R, Kish MS, Ashrafi E, Khalili M, et al. Reliability and validity of the Persian version of the World Health Organization-five well-being index. Int J Health Stud. 2015;1(1):17-9. doi: 10.22100/ijhs.v1i1.24.
  • 11. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992;87(5):733-42. [PubMed: 1591524].
  • 12. Radfar SR, Cousins SJ, Shariatirad S, Noroozi A, Rawson RA. Methamphetamine Use Among Patients Undergoing Methadone Maintenance Treatment in Iran; a Threat for Harm Reduction and Treatment Strategies: A Qualitative Study. Int J High Risk Behav Addict. 2016;5(4). doi: 10.5812/ijhrba.30327.
  • 13. Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013;24(6):e115-6. doi: 10.1016/j.drugpo.2013.05.003. [PubMed: 23773684].
  • 14. Simpson JL, Grant KM, Daly PM, Kelley SG, Carlo G, Bevins RA. Psychological Burden and Gender Differences in Methamphetamine-Dependent Individuals in Treatment. J Psychoactive Drugs. 2016;48(4):261-9. doi: 10.1080/02791072.2016.1213470. [PubMed: 27541988].
  • 15. Lee NK, Rawson RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev. 2008;27(3):309-17. doi: 10.1080/09595230801919494. [PubMed: 18368613].
  • 16. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002;59(9):817-24. [PubMed: 12215081].
  • 17. Sami S, Effatpanah M, Moradi A, Massah O. Matrix Model as an Intensive Rehabilitation in Three Methadone Services in Iran. Iran Rehabil J. 2017;15(3):293-8. doi: 10.29252/nrip.irj.15.3.293.
  • 18. Massah O, Effatpanah M, Shishehgar S. Matrix Model for Methamphetamine Dependence Among Iranian Female Methadone Patients: The First Report From the Most Populated Persian Gulf Country. Iran Rehabil J. 2017;15(3):193-8. doi: 10.29252/nrip.irj.15.3.193.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments